Zacks Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.2M Sell
54,316
-31,734
-37% -$14.1M 0.21% 122
2025
Q1
$41.7M Buy
86,050
+33,397
+63% +$16.2M 0.39% 73
2024
Q4
$21.2M Sell
52,653
-9,831
-16% -$3.96M 0.2% 123
2024
Q3
$29.1M Buy
62,484
+2,719
+5% +$1.26M 0.25% 104
2024
Q2
$28M Buy
59,765
+5,432
+10% +$2.55M 0.32% 77
2024
Q1
$22.7M Buy
54,333
+53,662
+7,997% +$22.4M 0.24% 104
2023
Q4
$273K Buy
+671
New +$273K ﹤0.01% 543
2023
Q3
Sell
-1,224
Closed -$431K 714
2023
Q2
$431K Sell
1,224
-430
-26% -$151K 0.01% 480
2023
Q1
$521K Sell
1,654
-13,031
-89% -$4.11M 0.01% 447
2022
Q4
$4.24M Buy
14,685
+1,043
+8% +$301K 0.06% 205
2022
Q3
$3.95M Sell
13,642
-15,649
-53% -$4.53M 0.06% 194
2022
Q2
$8.25M Buy
29,291
+376
+1% +$106K 0.13% 136
2022
Q1
$7.55M Buy
+28,915
New +$7.55M 0.1% 155
2021
Q4
Sell
-1,253
Closed -$227K 683
2021
Q3
$227K Sell
1,253
-30,207
-96% -$5.47M ﹤0.01% 565
2021
Q2
$6.34M Sell
31,460
-8,190
-21% -$1.65M 0.1% 160
2021
Q1
$8.52M Buy
39,650
+10,903
+38% +$2.34M 0.15% 135
2020
Q4
$6.79M Sell
28,747
-8,417
-23% -$1.99M 0.13% 140
2020
Q3
$10.1M Sell
37,164
-7,711
-17% -$2.1M 0.2% 110
2020
Q2
$13M Buy
44,875
+2,538
+6% +$737K 0.29% 84
2020
Q1
$10.1M Buy
42,337
+10,610
+33% +$2.52M 0.25% 99
2019
Q4
$6.95M Buy
31,727
+1,637
+5% +$358K 0.13% 131
2019
Q3
$5.1M Buy
+30,090
New +$5.1M 0.1% 148
2017
Q4
Sell
-7,937
Closed -$1.21M 653
2017
Q3
$1.21M Buy
+7,937
New +$1.21M 0.03% 334
2016
Q1
Sell
-4,464
Closed -$562K 690
2015
Q4
$562K Buy
4,464
+95
+2% +$12K 0.02% 397
2015
Q3
$455K Sell
4,369
-9
-0.2% -$937 0.02% 443
2015
Q2
$541K Buy
+4,378
New +$541K 0.02% 427
2014
Q3
Sell
-12,327
Closed -$1.17M 756
2014
Q2
$1.17M Buy
+12,327
New +$1.17M 0.04% 233